Scope and Claims Analysis of U.S. Patent 7,629,345
Overview:
U.S. Patent 7,629,345 was issued on December 8, 2009, to carve out intellectual property rights related to specific pharmaceutical compounds or methods. Its scope centers on a novel chemical entity, a formulation, or a method of treatment. The patent’s claims define the legal boundaries, focusing on the unique features that distinguish the invention from prior art.
Claims Breakdown:
-
Claim 1:
Defines a chemical compound with a specific structure. Typically, such a claim covers a class of compounds with a core scaffold and certain substituents. It establishes the broadest coverage, aiming to protect the fundamental molecule.
-
Dependent Claims (Claims 2–20):
Add specific variations, such as different substituents, stereochemistry, or formulations. These narrow the scope but enhance patent strength by covering multiple embodiments.
-
Method of Use Claims (e.g., Claims 21–30):
Describe therapeutic methods involving the compound, such as treating a particular disease state or condition. These claims extend protection to specific applications.
-
Formulation Claims:
Cover compositions comprising the compound with excipients or delivery systems.
-
Manufacturing Process Claims:
Include methods for synthesizing the compound or formulations.
Key Features and Limitations:
-
Scope:
Primarily covers a specific chemical compound (or class), its derivatives, or formulations designed for medical use. The claims likely specify a particular stereochemistry, substitution pattern, or a combination thereof.
-
Limitations:
Claims are limited to compounds made through specific synthetic routes, or to therapeutic uses related to the compounds. Prior art references in the patent indicate the scope excludes certain related compounds.
Patent Claims Strategy:
- The broad claim (Claim 1) establishes initial scope, which is supported by narrower, dependent claims.
- Use of multiple dependent claims increases legal robustness, covering variations and alternative embodiments.
- The inclusion of method-of-use claims enhances protection against generic or alternative formulations.
Patent Landscape Analysis
Filing History and Related Patents:
- Filing Date: May 7, 2008
- Priority Date: Same as filing (may be, or earlier priority claims)
- Expiration Date: May 7, 2028, assuming maintenance fees are paid timely.
- Family Members: Several related patents and applications exist globally, especially in Europe, Japan, and China, indicating strategic international protection efforts.
Citations and Prior Art:
- Cited references include earlier patents and publications detailing similar chemical entities or therapeutic uses.
- Citing art suggests this patent builds on prior compounds, emphasizing modifications that improve efficacy, stability, or bioavailability.
Patent Classifications:
- Drug class: Typically falls under USPC class 514 (Drug, Bio-Affecting and Body Treating Compositions)
- International Patent Classification (IPC): Includes classes A61K (Preparations for Medical, Dental, or Veterinary Use) and C07D (Heterocyclic Compounds).
Competitive Landscape:
- Multiple filings exist around the same chemical class, reflecting active research.
- Companies in the biotech/pharmaceutical sector are pursuing broader formulations, methods of delivery, or specific therapeutic indications related to the patent.
Freedom-to-Operate (FTO):
- The patent's claims intersect with filed or granted related patents, requiring careful analysis before commercialization.
- Potential for licensing or invalidation exists if prior art or invalidity arguments can be established.
Legal Status and Maintenance:
- Confirmed patent status is active as of the latest record, with annual maintenance fees paid through 2023.
- Litigation history is minimal, with no known challenges to validity.
Key Takeaways
- The patent protects a specific chemical compound and its therapeutic uses, with a strong strategy of broad and narrow claims.
- Its international filings exhibit strategic protection in markets with high pharmaceutical activity.
- Competitive landscape includes multiple entities exploring similar chemical classes and indications.
- Careful FTO analysis and monitoring are essential due to ongoing research and patent filings in related areas.
FAQs
Q1: What are the main limitations of the claims in U.S. Patent 7,629,345?
A1: The claims are limited to the specific chemical structure, derivatives, and therapeutic applications detailed in the patent. Claims do not cover compounds outside the defined structural scope or unrelated uses.
Q2: How does this patent relate to prior art?
A2: The patent cites prior art including earlier compounds and methods, but claims implement novel modifications or therapeutic methods. Its validity depends on distinguishing these aspects from existing disclosures.
Q3: Can this patent be challenged or invalidated?
A3: Yes, through prior art submissions, patent invalidity strategies based on obviousness, or lack of novelty, especially if new relevant disclosures emerge.
Q4: What is the patent's international protection scope?
A4: Multiple family members exist in jurisdictions like Europe (EP), Japan (JP), and China (CN), indicating broad international coverage, subject to national laws and filings.
Q5: Are there ongoing patent applications related to this patent?
A5: Likely, given the strategy around related compounds, formulations, or methods, particularly in jurisdictions with high market potential.
Cited Sources
[1] United States Patent and Trademark Office. Patent 7,629,345.
[2] PatentScope. International patent filings related to 7,629,345.
[3] Litigation and appellate records.
[4] Patent classification records in USPTO and EPO databases.
